Relapsed or Refractory Acute Myeloid Leukemia

Grant Details

Grantee Name:
 Dr. Steven Rosen
Organization: City of Hope

Country: USA

Project Name: A Phase I/II Trial of 8-Chloro-adenosine in Relapsed or Refractory Acute Myeloid Leukemia

Funding Year: 2015

Project period: 6 years

A Phase I/II Trial of 8-Chloro-adenosine in Relapsed or Refractory Acute Myeloid Leukemia

This phase I/II trial will assess the safety and efficacy of 8-Chloro-Adenosine (8-Cl-Ado), a new therapeutic small molecule that is preferentially toxic to cancer as opposed to normal cells. It has shown potent anticancer activity against leukemia cells and has been very well tolerated in an earlier human clinical trial evaluating safety for different blood cancer.

icon-social-share-linkedin Created with Sketch.
icon-play Created with Sketch.
icon-download Created with Sketch.